loading

Detail Search Results


Basic Information
Disease Name : Uveal melanoma
Regulator : HOXA11-AS
Target : CDKN1A
Clinical application :
Regulator dysregulation in Circulating Tumor Cells :
Target dysregulation in Circulating Tumor Cells : UP(LIHC,PAAD,PRAD,BRCA);DATA(GSE117623,GSE40174,GSE104209,GSE109761,GSE75367,GSE86978)
Regulatory Type : regulation
Level Of Regulation :
Regulation Direction : negatively-E
Experimental method for lncRNA-target : RIP;ChIP
Expression Pattern : upregulation
Experimental method for lncRNA expression : qPCR
Data Accession :
Influenced Function : cell proliferation(+);cell invasion(+)
Regulatory Mechanism : histone modification
Drugs :
Cancer Stem Cell :
Hallmark : Insensitivity to Antigrowth Signals;Tissue Invasion and Metastasis
Disease Category : Cancer
Disease Name2 : Uveal cancer
Regulator Type : lncRNA
Target Type : PCG
Regulator EnsembleID : ENSG00000240990
Target EnsembleID : ENSG00000124762
Regulator EntrezID : 221883
Target EntrezID: 1026
RegulatorAlias : HOXA-AS5|HOXA11-AS1|HOXA11AS|HOXA11S|NCRNA00076
TargetAlias : CAP20|CDKN1|CIP1|MDA-6|P21|SDI1|WAF1|p21CIP1
Regulator Location : GRCh38_7:27184507-27189298
Target Location :
Evidence : LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma;we demonstrated that HOXA11-AS functioned as a molecular sponge for miR-124, and overexpression of miR-124 attenuated the proliferation and invasion-promoting effect of HOXA11-AS.Mechanistically, RNA immunoprecipitation demonstrated that HOXA11-AS could simultaneously interact with enhancer of zeste homolog 2 (EZH2) to suppress its target p21 protein expression.
PubMedID :  28749709
Differential Expression Across TCGA
Cancer Type(Tumour VS Normal) HOXA11-AS CDKN1A
Mean Expression log2FoldChange FDR Mean Expression log2FoldChange FDR
BLCA(414 vs 19) 5.99644655 -0.646221521 0.123066692 123.746743 -1.604109109 2.58e-09
BRCA(1142 vs 114) 0.585994699 1.413713297 1.53e-14 54.98332457 -0.432945213 2.3e-05
CESC(306 vs 3) 4.305793932 -2.464538099 0.039739904 180.5200937 -0.245517318 0.794905509
CHOL(36 vs 9) 0.237821927 2.538278537 0.070345516 109.9561302 -0.688736228 0.072438932
COAD(505 vs 41) 16.70122817 -0.051829466 0.829663877 79.92626964 -1.166714275 8.68e-14
ESCA(185 vs 13) 2.966320372 2.383333983 0.000794526 82.9007361 -0.390264262 0.330512608
GBM(170 vs 5) 1.315368863 8.04661709 1.11e-08 102.597028 1.574483273 0.003841375
HNSC(522 vs 44) 0.714959673 4.623922516 4.14e-32 185.5904186 0.047968229 0.772345848
KICH(66 vs 25) 3.39017003 0.861142659 0.044350822 60.44255539 -0.400925973 0.190696193
KIRC(546 vs 72) 0.784804166 -1.316599371 4.43e-13 113.7269013 0.617700027 2.52e-08
KRIP(291 vs 32) 1.891637586 -0.342746437 0.477789077 170.897996 1.310403918 1.84e-13
LIHC(374 vs 50) 0.246463613 4.949600743 3.73e-22 70.65386308 -0.726680086 4.42e-05
LUAD(542 vs 59) 0.372353217 4.008716371 2.51e-17 61.67730222 -0.949328681 2.99e-15
LUSC(504 vs 51) 1.301451556 6.235710512 3.91e-70 90.10775799 -0.942822529 3.08e-13
PAAD(179 vs 4) 1.223067318 2.87549756 0.157179803 100.260063 0.090044348 0.933741373
PCPG(184 vs 3) 0.454624793 -1.880486916 0.328935542 103.8369348 0.52399331 0.501285024
PRAD(506 vs 52) 57.07931304 0.824046147 5.91e-08 53.36497024 -0.525901657 0.00126678
READ(167 vs 10) 15.29943582 0.18966394 0.754429453 68.4301542 -1.044023816 0.000829103
SARC(263 vs 2) 7.339992625 -1.023868826 0.759376034 115.7880744 0.827683108 0.590538345
SKCM(472 vs 1) 2.324511658 2.555662817 0.999958931 87.60258819 1.098394912 0.999958931
STAD(416 vs 37) 3.146020421 3.63825029 3.17e-18 51.21163985 -1.415775833 1.35e-17
THCA(513 vs 59) 0.176132299 3.448179082 1.98e-17 153.1238884 1.099452734 4.86e-17
THYM(120 vs 2) 0.077780159 0.403209995 0.937612178 23.74850998 -0.196386573 0.938389697
UCEC(558 vs 35) 6.650659658 -1.237521882 0.000170051 78.08389552 0.094169729 0.7275202
Boxplot Display

Copyright © 2019 College of Bioinformatics Science and Technology, Harbin Medical University All rights reserved.

黑ICP备2022004059号